AU2002251050A1 - Thiocyanate ions for preventing and treating bse and similar animal and human diseases - Google Patents

Thiocyanate ions for preventing and treating bse and similar animal and human diseases

Info

Publication number
AU2002251050A1
AU2002251050A1 AU2002251050A AU2002251050A AU2002251050A1 AU 2002251050 A1 AU2002251050 A1 AU 2002251050A1 AU 2002251050 A AU2002251050 A AU 2002251050A AU 2002251050 A AU2002251050 A AU 2002251050A AU 2002251050 A1 AU2002251050 A1 AU 2002251050A1
Authority
AU
Australia
Prior art keywords
preventing
human diseases
thiocyanate ions
similar animal
bse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002251050A
Inventor
Wolfgang Weuffen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002251050A1 publication Critical patent/AU2002251050A1/en
Abandoned legal-status Critical Current

Links

AU2002251050A 2001-03-01 2002-02-28 Thiocyanate ions for preventing and treating bse and similar animal and human diseases Abandoned AU2002251050A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10109959.2 2001-03-01
DE10132444.8 2001-07-04

Publications (1)

Publication Number Publication Date
AU2002251050A1 true AU2002251050A1 (en) 2002-09-19

Family

ID=

Similar Documents

Publication Publication Date Title
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
IL160933A0 (en) Methods and compositions for treating ?cap associated diseases
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU2002352706A1 (en) N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
EP1416961A4 (en) Composition and method for the treatment of disease
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
HK1074785A1 (en) Animal feeds including actives and methods of using same
AU2002346504A1 (en) Therapeutic protein and treatments
MXPA03008582A (en) Agents and methods for treatment of cancer.
EP1461047A4 (en) Compositions and methods for animal treatment
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU2002241343A1 (en) Decoy compositions for treating and preventing brain diseases and disorders
EP1389972A4 (en) Animal treatment and marking system
AU2002319286A1 (en) Skin treatment
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2002244727A1 (en) Absorbent body and animal litter
AU2002251050A1 (en) Thiocyanate ions for preventing and treating bse and similar animal and human diseases
IL148189A0 (en) Chemically-stabilized chlorite solutions for treating cancer and other diseases
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease